<Record>
<Term>HIV Fusion Inhibitors</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Anti-HIV Agents</ParentTerm>
<ParentTerm>Molecular Mechanisms of Pharmacological Action</ParentTerm>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Therapeutic Uses/Anti-Infective Agents/Antiviral Agents/Anti-Retroviral Agents/Anti-HIV Agents/HIV Fusion Inhibitors</ClassificationPath>
<ClassificationPath>Chemical Actions and Uses/Pharmacologic Actions/Molecular Mechanisms of Pharmacological Action/HIV Fusion Inhibitors</ClassificationPath>
<BroaderTerm>Therapeutic Uses</BroaderTerm>
<BroaderTerm>Pharmacologic Actions</BroaderTerm>
<BroaderTerm>Antiviral Agents</BroaderTerm>
<BroaderTerm>Anti-Infective Agents</BroaderTerm>
<BroaderTerm>HIV Fusion Inhibitors</BroaderTerm>
<BroaderTerm>Chemical Actions and Uses</BroaderTerm>
<BroaderTerm>Anti-HIV Agents</BroaderTerm>
<BroaderTerm>Molecular Mechanisms of Pharmacological Action</BroaderTerm>
<BroaderTerm>Anti-Retroviral Agents</BroaderTerm>
<Synonym>HIV Entry Inhibitors</Synonym>
<Synonym>HIV Fusion Inhibitors</Synonym>
<Synonym>HIV Cell Fusion Inhibitors</Synonym>
<Description>Inhibitors of the fusion of HIV to host cells, preventing viral entry. This includes compounds that block attachment of HIV ENVELOPE PROTEIN GP120 to CD4 RECEPTORS.</Description>
<Source>MeSH</Source>
</Record>
